January 14th, 2022, ADCIS joins the Evolucare group!
After being long-standing partners in the RetinOpTIC project and associates in OphtAI since 2019, ADCIS officially joined the Evolucare group on January 14th, 2022. With 27 years of experience in signal processing for healthcare industry (ophthalmology, dermatology, life sciences) as well as in many high-tech industries (drones, materials, authentication…), Bruno Laÿ, Chairman and CEO of ADCIS and his team join the Evolucare group’s workforce to accelerate their joint development.
ADCIS’ expertise in image processing and artificial intelligence is recognized in France and internationally. This acquisition will accelerate the development of ADCIS’ activities in Computer Vision and will allow Evolucare to better prepare itself to meet the challenges of tomorrow’s healthcare IT!
Who is Evolucare?
Evolucare is a software company that combines experience and agility to ensure its mission of connecting the world of healthcare and giving it the efficient and economical means to provide better care.
Evolucare’s strength lies in the diversity of its teams’ expertise, both business and technical, and in the responsiveness of its support team. In addition to the pool of skills of its dynamic forces, the teams human values fully contribute to the success of the group.
What are the objectives behind this merger?
The strategy that led to this acquisition is clear:
– Accelerate the development of the Aphelion solution to support ADCIS’ historical business
– Strengthen ADCIS’ teams to enable it to take on ambitious multidisciplinary projects (development and innovation capacity, quality management system, etc.)
– To consolidate an Ophthalmology cluster around OphtAI and to position the group as a major player in healthcare AI
🧑🎤 Bruno Laÿ – ADCIS: “I’m proud for all the ADCIS team to have concluded with Evolucare the acquisition of the company I created 27 years ago. Thanks to the OphtAI partnership set up in 2019, ADCIS was able to appreciate EVOLUCARE’s expertise in the field of digital health, the competence of its technical teams and its strong presence in the medical market and more particularly in ophthalmology. I look forward to seeing the results of this acquisition which will enable Evolucare Group to become the undisputed leader in this market.”
🧑🎤 Philippe Blanco – EVOLUCARE: “We are proud to welcome ADCIS to the Evolucare Group. The expertise of its teams in artificial intelligence will help us push OphtAI further and strategically prepare the group for the healthcare IT challenges of tomorrow.”